Akero Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Akero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 69.4M shares, a 24.9% increase year-over-year.
  • Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 52.6M shares, a 34.8% increase from 2022.
  • Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39M shares, a 11.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 69.4M +13.8M +24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 69.2M +17.3M +33.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 59.3M +12.4M +26.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 52.6M +13.6M +34.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 55.6M +16.9M +43.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 51.9M +16.5M +46.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 46.9M +11.9M +34.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 39M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 38.7M +3.8M +10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 35.4M +569K +1.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 35M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 34.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 34.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.